Dr. Johan MAERTENS
Claim this profileUz Leuven
Studies Fungal Infection
Studies Invasive Aspergillosis
2 reported clinical trials
5 drugs studied
Clinical Trials Johan MAERTENS is currently running
Olorofim vs AmBisome®
for Aspergillosis
This trial is testing a new antifungal drug called olorofim against an existing treatment, AmBisome®, in patients with tough fungal infections. These patients have limited options because their infections resist current treatments or they can't tolerate them. Olorofim works differently from other drugs, can be taken orally, and has fewer interactions with other medications. AmBisome is a liposomal formulation of amphotericin B, known for its broad-spectrum antifungal activity and reduced toxicity compared to conventional amphotericin B.
Recruiting2 awards Phase 34 criteria
CYAD-02
for Leukemia/Preleukemia
This trial tests CYAD-02, a cell-based treatment, in patients with relapsed or refractory AML or MDS who haven't responded to standard treatments. Patients receive mild chemotherapy first, followed by CYAD-02 infusions to target cancer cells. If effective, they may receive additional doses.
Recruiting3 awards Phase 16 criteria
More about Johan MAERTENS
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Johan MAERTENS has experience with
- AmBisome®
- Olorofim
- CYAD-02
- ENDOXAN
- Fludara
Breakdown of trials Johan MAERTENS has run
Fungal Infection
Invasive Aspergillosis
Myelodysplastic Syndrome
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Johan MAERTENS specialize in?
Johan MAERTENS focuses on Fungal Infection and Invasive Aspergillosis. In particular, much of their work with Fungal Infection has involved treating patients, or patients who are undergoing treatment.
Is Johan MAERTENS currently recruiting for clinical trials?
Yes, Johan MAERTENS is currently recruiting for 2 clinical trials in the USA. If you're interested in participating, you should apply.
Are there any treatments that Johan MAERTENS has studied deeply?
Yes, Johan MAERTENS has studied treatments such as AmBisome®, Olorofim, CYAD-02.
What is the best way to schedule an appointment with Johan MAERTENS?
Apply for one of the trials that Johan MAERTENS is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.